Belite Bio, Inc

Belite Bio, Incverified

BLTE

Price:

$164.11

Market Cap:

$6.46B

Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that is in phase 3 clinical trial. The company is also developing LBS-009, an anti-retinol binding protein 4 oral therapy targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, which is in ...[Read more]

Industry

Biotechnology

IPO Date

2022-04-29

Stock Exchange

NASDAQ

Ticker

BLTE

The Current Ratio as of March 2026 (TTM) for Belite Bio, Inc (BLTE) is 34.37

According to Belite Bio, Inc’s latest financial reports and current stock price. The company's current Current Ratio is 34.37. This represents a change of 64.64% compared to the average of 20.87 of the last 4 quarters.

Belite Bio, Inc (BLTE) Historical Current Ratio (quarterly & annually)

How has BLTE Current Ratio performed in the past?

The mean historical Current Ratio of Belite Bio, Inc over the last ten years is 17.75. The current 34.37 Current Ratio has changed 19.27% with respect to the historical average. Over the past ten years (40 quarters), BLTE's Current Ratio was at its highest in in the June 2022 quarter at 35.01K. The Current Ratio was at its lowest in in the March 2022 quarter at 0.

Quarterly (TTM)
Annual

Average

17.75

Median

22.33

Minimum

0

Maximum

26.41

Belite Bio, Inc (BLTE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Belite Bio, Inc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 90.84%

Maximum Annual Current Ratio = 26.41

Minimum Annual Increase = -100.00%

Minimum Annual Current Ratio = 0

Quarterly (TTM)
Annual
YearCurrent RatioChange
20250-100.00%
202424.31-1.80%
202324.7621.68%
202220.3590.84%
202110.66-59.63%

Belite Bio, Inc (BLTE) Average Current Ratio

How has BLTE Current Ratio performed in the past?

The current Current Ratio of Belite Bio, Inc (BLTE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

16.36

5-year avg

16.01

10-year avg

17.75

Belite Bio, Inc (BLTE) Current Ratio vs. Peers

How is BLTE’s Current Ratio compared to its peers?

Belite Bio, Inc’s Current Ratio is greater than Mirum Pharmaceuticals, Inc. (2.67), greater than Ligand Pharmaceuticals Incorporated (22.23), greater than ADMA Biologics, Inc. (6.71), greater than Praxis Precision Medicines, Inc. (10.22), greater than ACADIA Pharmaceuticals Inc. (3.83), greater than Soleno Therapeutics, Inc. (5.80), greater than Dyne Therapeutics, Inc. (22.25), greater than Arcutis Biotherapeutics, Inc. (3.17), greater than Viking Therapeutics, Inc. (9.33), greater than Crinetics Pharmaceuticals, Inc. (12.32),

Build a custom stock screener for Belite Bio, Inc (BLTE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Belite Bio, Inc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Belite Bio, Inc (BLTE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Belite Bio, Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Belite Bio, Inc's Current Ratio?

How is the Current Ratio calculated for Belite Bio, Inc (BLTE)?

What is the highest Current Ratio for Belite Bio, Inc (BLTE)?

What is the 3-year average Current Ratio for Belite Bio, Inc (BLTE)?

What is the 5-year average Current Ratio for Belite Bio, Inc (BLTE)?

How does the current Current Ratio for Belite Bio, Inc (BLTE) compare to its historical average?